Introduction: Breast cancer remains the leading malignancy among women, and early detection is crucial to reduce mortality. Although mammography is the standard screening tool, its diagnostic accuracy is limited by interobserver variability and false results. In this context, artificial intelligence (AI) emerges as a p...
José Alttmar da Silva, Mariana Lemos Almeida, Pedro Carvalho Roncato Rodrigues et al.· Mastology· 0 citations
Introduction: Breast cancer (BC) is a biologically heterogeneous disease and HER2 expression presents important prognostic implications. Recently, the HER2-low BC has been recognized, defined as HER2 immunohistochemistry (IHC) 1+ or 2+ without gene amplification, whereas HER2-zero tumors show no detectable expression....
Deborah Abucarma Soares, M. E. T. Mendes, A. Carvalho et al.· Mastology· 0 citations
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression, with limited therapeutic options. TNBC exhibits high tumor heterogeneity and a worse prognosis, including...
Vyvian Paes de Oliveira, Deborah Abucarma Soares, M. E. T. Mendes et al.· Mastology· 0 citations
SLNB after chemotherapy is effective in suspected axillary involvement, and has been proven effective in patients without lymph node metastases and in those with recurrence, especially when ≥3 negative sentinel nodes are identified.
M. E. T. Mendes, Elisa de Araujo Meireles Lewergger, Sophia Fonseca Chagas et al.· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
